[S02DA03, antipyrine, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Antipyrine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Isosorbide mononitrate.]
[J01GA01, streptomycin, Isosorbide mononitrate may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01CG01, sulbactam, Isosorbide mononitrate may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Isosorbide mononitrate.]
[J01EC01, sulfamethoxazole, The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Isosorbide mononitrate.]
[J01EB04, sulfapyridine, The risk or severity of methemoglobinemia can be increased when Sulfapyridine is combined with Isosorbide mononitrate.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Isosorbide mononitrate may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Tetracaine.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Isosorbide mononitrate.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the vasodilatory activities of Isosorbide mononitrate.]
[R03DA04, theophylline, Theophylline may increase the vasodilatory activities of Isosorbide mononitrate.]
[C10AD03, nicofuranose, Nicofuranose may increase the vasodilatory activities of Isosorbide mononitrate.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Isosorbide mononitrate.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Thioridazine is combined with Isosorbide mononitrate.]
[G04BE06, moxisylyte, Moxisylyte may increase the vasodilatory activities of Isosorbide mononitrate.]
[N05AL03, tiapride, Isosorbide mononitrate may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Timolol is combined with Isosorbide mononitrate.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01AA12, tobramycin, Isosorbide mononitrate may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M02AX02, tolazoline, Tolazoline may increase the vasodilatory activities of Isosorbide mononitrate.]
[V04CA01, tolbutamide, Isosorbide mononitrate may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[C01DX11, trapidil, Trapidil may increase the vasodilatory activities of Isosorbide mononitrate.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Isosorbide mononitrate.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Isosorbide mononitrate may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A03AA05, trimebutine, Trimebutine may increase the vasodilatory activities of Isosorbide mononitrate.]
[N03AC02, trimethadione, Trimethadione may increase the vasodilatory activities of Isosorbide mononitrate.]
[C02BA01, trimethaphan, Trimethaphan may increase the vasodilatory activities of Isosorbide mononitrate.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Azilsartan medoxomil.]
[R03DX07, roflumilast, Roflumilast may increase the hypotensive activities of Isosorbide mononitrate.]
[L01FX04, ipilimumab, Isosorbide mononitrate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Isosorbide mononitrate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[S01AA28, vancomycin, Isosorbide mononitrate may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Isosorbide mononitrate may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Isosorbide mononitrate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, Verapamil may increase the vasodilatory activities of Isosorbide mononitrate.]
[N06AX09, viloxazine, Isosorbide mononitrate may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[C04AX07, vincamine, Vincamine may increase the vasodilatory activities of Isosorbide mononitrate.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[B01AA03, warfarin, Isosorbide mononitrate may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M05BA05, tiludronic acid, Isosorbide mononitrate may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Isosorbide mononitrate may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Isosorbide mononitrate may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Isosorbide mononitrate may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Isosorbide mononitrate may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Isosorbide mononitrate may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Isosorbide mononitrate may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, The risk or severity of adverse effects can be increased when Atenolol is combined with Isosorbide mononitrate.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[B03XA04, peginesatide, Isosorbide mononitrate may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[G04BE10, avanafil, Avanafil may increase the vasodilatory activities of Isosorbide mononitrate.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A08AA11, lorcaserin, Isosorbide mononitrate may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Isosorbide mononitrate may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L02BB04, enzalutamide, Isosorbide mononitrate may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[C04AA31, bamethan, Bamethan may increase the vasodilatory activities of Isosorbide mononitrate.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Isosorbide mononitrate.]
[D02BA02, octinoxate, Isosorbide mononitrate may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[N04BD02, rasagiline, Rasagiline may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[C08CA13, lercanidipine, Lercanidipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[V09IX04, fluorodeoxyglucose F18, Isosorbide mononitrate may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G04BE03, sildenafil, The risk or severity of hypotension can be increased when Isosorbide mononitrate is combined with Sildenafil.]
[V08CA11, gadofosveset, Isosorbide mononitrate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Isosorbide mononitrate may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C04AX11, bencyclane, Bencyclane may increase the vasodilatory activities of Isosorbide mononitrate.]
[A10BH04, alogliptin, Isosorbide mononitrate may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Isosorbide mononitrate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Isosorbide mononitrate may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Benzocaine.]
[L03AA12, ancestim, Isosorbide mononitrate may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of methemoglobinemia can be increased when Celecoxib is combined with Isosorbide mononitrate.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01EE01, trametinib, Isosorbide mononitrate may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Isosorbide mononitrate may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Isosorbide mononitrate may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, Bepridil may increase the vasodilatory activities of Isosorbide mononitrate.]
[C02KX05, riociguat, Isosorbide mononitrate may increase the hypotensive activities of Riociguat.]
[A10BJ03, lixisenatide, Isosorbide mononitrate may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Macitentan may increase the vasodilatory activities of Isosorbide mononitrate.]
[N06AX26, vortioxetine, Isosorbide mononitrate may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J05AP08, sofosbuvir, Isosorbide mononitrate may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Isosorbide mononitrate may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Acebutolol.]
[N05CH03, tasimelteon, Isosorbide mononitrate may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Isosorbide mononitrate may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Isosorbide mononitrate may decrease the excretion rate of Formestane which could result in a higher serum level.]
[N07CA01, betahistine, Betahistine may increase the vasodilatory activities of Isosorbide mononitrate.]
[S01ED02, betaxolol, The risk or severity of adverse effects can be increased when Betaxolol is combined with Isosorbide mononitrate.]
[V03AB34, fomepizole, Isosorbide mononitrate may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Isosorbide mononitrate may increase the hypotensive activities of Bethanidine.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Empagliflozin.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S03AA06, gentamicin, Isosorbide mononitrate may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AF03, edoxaban, Isosorbide mononitrate may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N02BE01, acetaminophen, The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Isosorbide mononitrate.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB37, idarucizumab, Isosorbide mononitrate may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Isosorbide mononitrate.]
[L01XG03, ixazomib, Isosorbide mononitrate may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Selexipag may increase the vasodilatory activities of Isosorbide mononitrate.]
[M04AB05, lesinurad, Isosorbide mononitrate may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N03AX23, brivaracetam, Isosorbide mononitrate may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[N05BA08, bromazepam, Isosorbide mononitrate may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Bromocriptine.]
[A02AD05, aluminum magnesium silicate, Isosorbide mononitrate may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C08CA01, amlodipine, Amlodipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AX23, butalamine, Butalamine may increase the vasodilatory activities of Isosorbide mononitrate.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Isosorbide mononitrate.]
[C07AA19, bupranolol, Isosorbide mononitrate may increase the hypotensive activities of Bupranolol.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Arsenic trioxide.]
[M02AA03, clofezone, Isosorbide mononitrate may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[R03DA08, bamifylline, Bamifylline may increase the vasodilatory activities of Isosorbide mononitrate.]
[A06AH05, naldemedine, Isosorbide mononitrate may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Isosorbide mononitrate may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may increase the vasodilatory activities of Isosorbide mononitrate.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Benazepril is combined with Isosorbide mononitrate.]
[P01CA02, benznidazole, Isosorbide mononitrate may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, Linezolid may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[J05AF06, abacavir, Isosorbide mononitrate may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Isosorbide mononitrate may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[J01MA23, delafloxacin, Isosorbide mononitrate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Isosorbide mononitrate may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isosorbide mononitrate.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Nesiritide.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Isosorbide mononitrate may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[C04AX20, buflomedil, Buflomedil may increase the vasodilatory activities of Isosorbide mononitrate.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Isosorbide mononitrate may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Captopril.]
[L02BB05, apalutamide, Isosorbide mononitrate may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Isosorbide mononitrate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C07AG02, carvedilol, Carvedilol may increase the vasodilatory activities of Isosorbide mononitrate.]
[B02BX09, fostamatinib, Fostamatinib may increase the vasodilatory activities of Isosorbide mononitrate.]
[L04AA37, baricitinib, Isosorbide mononitrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01GB14, plazomicin, Isosorbide mononitrate may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Celiprolol may increase the vasodilatory activities of Isosorbide mononitrate.]
[A16AX14, migalastat, Isosorbide mononitrate may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Isosorbide mononitrate may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[C04AX26, cetiedil, Cetiedil may increase the vasodilatory activities of Isosorbide mononitrate.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D08AE05, chloroxylenol, Isosorbide mononitrate may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A06AX05, prucalopride, Isosorbide mononitrate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Cilazapril.]
[B01AC23, cilostazol, Cilostazol may increase the vasodilatory activities of Isosorbide mononitrate.]
[N06BA14, solriamfetol, Isosorbide mononitrate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C09CA06, candesartan, Isosorbide mononitrate may increase the hypotensive activities of Candesartan.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N07XX11, pitolisant, Isosorbide mononitrate may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M09AX08, golodirsen, Isosorbide mononitrate may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Isosorbide mononitrate may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[R02AA03, dichlorobenzyl alcohol, Isosorbide mononitrate may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Isosorbide mononitrate may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C08CA16, clevidipine, Clevidipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C02AA06, methoserpidine, Isosorbide mononitrate may increase the hypotensive activities of Methoserpidine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Opicapone.]
[C01CA14, dopexamine, Dopexamine may increase the vasodilatory activities of Isosorbide mononitrate.]
[A03AD02, drotaverin, Drotaverine may increase the vasodilatory activities of Isosorbide mononitrate.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[V08CA05, mangafodipir, Isosorbide mononitrate may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C08CA17, levamlodipine, Levamlodipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[P01BA01, chloroquine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Isosorbide mononitrate.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Isosorbide mononitrate.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N02BA03, choline salicylate, Isosorbide mononitrate may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, Vinpocetine may increase the vasodilatory activities of Isosorbide mononitrate.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M01AX25, chondroitin sulfates, Isosorbide mononitrate may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Vericiguat.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may increase the vasodilatory activities of Isosorbide mononitrate.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01DX05, chromonar, Carbocromen may increase the vasodilatory activities of Isosorbide mononitrate.]
[C01DB01, flosequinan, Flosequinan may increase the vasodilatory activities of Isosorbide mononitrate.]
[N02BG07, flupirtine, Isosorbide mononitrate may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[H04AA02, dasiglucagon, Isosorbide mononitrate may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N07CA02, cinnarizine, Cinnarizine may increase the vasodilatory activities of Isosorbide mononitrate.]
[S03AA07, ciprofloxacin, Ciprofloxacin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01XA01, cisplatin, Isosorbide mononitrate may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, Citalopram may increase the vasodilatory activities of Isosorbide mononitrate.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AB03, ioflupane I-123, Isosorbide mononitrate may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Isosorbide mononitrate may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Isosorbide mononitrate may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Isosorbide mononitrate.]
[N06AA04, clomipramine, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Clomipramine.]
[N03AE01, clonazepam, Isosorbide mononitrate may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The risk or severity of adverse effects can be increased when Clonidine is combined with Isosorbide mononitrate.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, The risk or severity of adverse effects can be increased when Clozapine is combined with Isosorbide mononitrate.]
[J01GB12, arbekacin, Isosorbide mononitrate may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[C02KB01, metyrosine, Isosorbide mononitrate may increase the hypotensive activities of Metyrosine.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M04AC01, colchicine, Isosorbide mononitrate may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Isosorbide mononitrate may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Desflurane.]
[A04AA03, tropisetron, Isosorbide mononitrate may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, Ifenprodil may increase the vasodilatory activities of Isosorbide mononitrate.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J05AB14, valganciclovir, Isosorbide mononitrate may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Isosorbide mononitrate may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Isosorbide mononitrate may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Isosorbide mononitrate may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Isosorbide mononitrate may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Isosorbide mononitrate may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A03AX10, isometheptene, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Isometheptene.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[V04CH02, indigo carmine, Isosorbide mononitrate may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[N05CC01, chloral hydrate, Isosorbide mononitrate may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[N03AG01, valproic acid, The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Isosorbide mononitrate.]
[C04AC03, inositol niacinate, Inositol nicotinate may increase the vasodilatory activities of Isosorbide mononitrate.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05BA10, ketazolam, Isosorbide mononitrate may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C08CA09, lacidipine, Isosorbide mononitrate may increase the hypotensive activities of Lacidipine.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Isosorbide mononitrate.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N07BC04, lofexidine, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Lofexidine.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Lisinopril is combined with Isosorbide mononitrate.]
[A06AD01, magnesium carbonate, Isosorbide mononitrate may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, Manidipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01EB10, adenosine, Adenosine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C04AX01, cyclandelate, Cyclandelate may increase the vasodilatory activities of Isosorbide mononitrate.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Isosorbide mononitrate may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The risk or severity of methemoglobinemia can be increased when Cyclophosphamide is combined with Isosorbide mononitrate.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[S01XA18, cyclosporine, Cyclosporine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06AG02, moclobemide, Moclobemide may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[C09AA13, moexipril, The risk or severity of adverse effects can be increased when Moexipril is combined with Isosorbide mononitrate.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC05, moxonidine, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Moxonidine.]
[G04BE09, vardenafil, Vardenafil may increase the vasodilatory activities of Isosorbide mononitrate.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Isosorbide mononitrate.]
[C02CC04, debrisoquin, Isosorbide mononitrate may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Isosorbide mononitrate.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N07BB05, nalmefene, Isosorbide mononitrate may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, Nebivolol may increase the vasodilatory activities of Isosorbide mononitrate.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06AX06, nefazodone, Isosorbide mononitrate may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Nicorandil may increase the vasodilatory activities of Isosorbide mononitrate.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06AA01, desipramine, Isosorbide mononitrate may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Aliskiren.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may increase the vasodilatory activities of Isosorbide mononitrate.]
[P03AC04, permethrin, Isosorbide mononitrate may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[V03AH01, diazoxide, Diazoxide may increase the vasodilatory activities of Isosorbide mononitrate.]
[R05DA08, pholcodine, Isosorbide mononitrate may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C02DG01, pinacidil, Pinacidil may increase the vasodilatory activities of Isosorbide mononitrate.]
[A03AX04, pinaverium, Pinaverium may increase the vasodilatory activities of Isosorbide mononitrate.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Pipamperone.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, Isradipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[D07XC04, diflucortolone, Isosorbide mononitrate may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01AA05, digoxin, Isosorbide mononitrate may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Isosorbide mononitrate may increase the hypotensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may increase the vasodilatory activities of Isosorbide mononitrate.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[B01AC21, treprostinil, Treprostinil may increase the vasodilatory activities of Isosorbide mononitrate.]
[H03BC01, potassium perchlorate, Isosorbide mononitrate may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C08DB01, diltiazem, Diltiazem may increase the vasodilatory activities of Isosorbide mononitrate.]
[V03AB09, dimercaprol, Isosorbide mononitrate may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Isosorbide mononitrate may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Quinapril is combined with Isosorbide mononitrate.]
[B01AC07, dipyridamole, Dipyridamole may increase the vasodilatory activities of Isosorbide mononitrate.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Isosorbide mononitrate.]
[S01AX06, resorcinol, Isosorbide mononitrate may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05AX08, risperidone, Isosorbide mononitrate may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, Isosorbide mononitrate may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Isosorbide mononitrate.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Tadalafil may increase the vasodilatory activities of Isosorbide mononitrate.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C02KX02, ambrisentan, Ambrisentan may increase the vasodilatory activities of Isosorbide mononitrate.]
[C01EB18, ranolazine, Ranolazine may increase the vasodilatory activities of Isosorbide mononitrate.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06AA12, doxepin, Isosorbide mononitrate may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Sevoflurane.]
[A08AA10, sibutramine, Isosorbide mononitrate may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Isosorbide mononitrate may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, Isosorbide mononitrate may increase the hypotensive activities of Spirapril.]
[R03DA01, dyphylline, Dyphylline may increase the vasodilatory activities of Isosorbide mononitrate.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C07AB13, talinolol, Isosorbide mononitrate may increase the hypotensive activities of Talinolol.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[G04CA03, terazosin, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Terazosin.]
[G04BD05, terodiline, Terodiline may increase the vasodilatory activities of Isosorbide mononitrate.]
[C09AA02, enalapril, The risk or severity of adverse effects can be increased when Enalapril is combined with Isosorbide mononitrate.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Trandolapril is combined with Isosorbide mononitrate.]
[C02CA06, urapidil, Urapidil may increase the vasodilatory activities of Isosorbide mononitrate.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C08CA12, mepirodipine, Barnidipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C09AA15, zofenopril, Isosorbide mononitrate may increase the hypotensive activities of Zofenopril.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the vasodilatory activities of Isosorbide mononitrate.]
[N05CF01, zopiclone, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Zopiclone.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Guanfacine is combined with Isosorbide mononitrate.]
[B01AC11, iloprost, Iloprost may increase the vasodilatory activities of Isosorbide mononitrate.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may increase the vasodilatory activities of Isosorbide mononitrate.]
[C01DA13, erythrityl tetranitrate, Erythrityl tetranitrate may increase the vasodilatory activities of Isosorbide mononitrate.]
[L03AX05, pidotimod, Isosorbide mononitrate may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Isosorbide mononitrate may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Amifostine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N03AD01, ethosuximide, Ethosuximide may increase the vasodilatory activities of Isosorbide mononitrate.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L04AD02, tacrolimus, Tacrolimus may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[P01AX07, trimetrexate, Isosorbide mononitrate may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Isosorbide mononitrate may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Isosorbide mononitrate may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Isosorbide mononitrate may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C08CA02, felodipine, Felodipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C08EA01, fendiline, Fendiline may increase the vasodilatory activities of Isosorbide mononitrate.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Isosorbide mononitrate.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[G04BD02, flavoxate, Isosorbide mononitrate may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J02AX01, flucytosine, Isosorbide mononitrate may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Isosorbide mononitrate may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, Flunarizine may increase the vasodilatory activities of Isosorbide mononitrate.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive and vasodilatory activities of Isosorbide mononitrate.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06AB03, fluoxetine, Fluoxetine may increase the vasodilatory activities of Isosorbide mononitrate.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05AG01, fluspirilene, Fluspirilene may increase the vasodilatory activities of Isosorbide mononitrate.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Isosorbide mononitrate.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01BC03, tegafur, Isosorbide mononitrate may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C08DA02, gallopamil, Gallopamil may increase the vasodilatory activities of Isosorbide mononitrate.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Isosorbide mononitrate.]
[C10AB04, gemfibrozil, Isosorbide mononitrate may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Isosorbide mononitrate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01CA21, cafedrine, Cafedrine may increase the vasodilatory activities of Isosorbide mononitrate.]
[N03AD03, methsuximide, Methsuximide may increase the vasodilatory activities of Isosorbide mononitrate.]
[A10BB07, glipizide, Isosorbide mononitrate may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Isosorbide mononitrate.]
[C05AE01, nitroglycerin, Nitroglycerin may increase the vasodilatory activities of Isosorbide mononitrate.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Isosorbide mononitrate.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01CE03, enoximone, Enoximone may increase the vasodilatory activities of Isosorbide mononitrate.]
[C07AB09, esmolol, The risk or severity of adverse effects can be increased when Esmolol is combined with Isosorbide mononitrate.]
[M01CB04, aurothioglucose, Isosorbide mononitrate may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Isosorbide mononitrate may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Fosinopril is combined with Isosorbide mononitrate.]
[S01EX01, guanethidine, Isosorbide mononitrate may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05AD01, haloperidol, Haloperidol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Halothane.]
[N05AH04, quetiapine, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Quetiapine.]
[N06BX13, idebenone, Isosorbide mononitrate may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C09CA01, losartan, The risk or severity of adverse effects can be increased when Losartan is combined with Isosorbide mononitrate.]
[G03DC01, allylestrenol, Isosorbide mononitrate may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may increase the vasodilatory activities of Isosorbide mononitrate.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Isosorbide mononitrate.]
[C01DX06, hexobendine, Hexobendine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C08CA10, nilvadipine, Nilvadipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[M02AA26, nimesulide, Nimesulide may increase the vasodilatory activities of Isosorbide mononitrate.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Perindopril is combined with Isosorbide mononitrate.]
[C02DB02, hydralazine, Hydralazine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Isosorbide mononitrate may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[G04BD06, propiverine, Isosorbide mononitrate may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Isosorbide mononitrate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Isosorbide mononitrate.]
[C02AC06, rilmenidine, Isosorbide mononitrate may increase the hypotensive activities of Rilmenidine.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[B05XA08, sodium acetate, Isosorbide mononitrate may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Ifosfamide.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Sufentanil is combined with Isosorbide mononitrate.]
[N06AA02, imipramine, The risk or severity of adverse effects can be increased when Imipramine is combined with Isosorbide mononitrate.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Paclitaxel.]
[R01AD07, tixocortol, Isosorbide mononitrate may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Isosorbide mononitrate.]
[L01CE01, topotecan, Isosorbide mononitrate may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C02CA02, indoramin, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Indoramin.]
[C04AX17, vinburnine, Vinburnine may increase the vasodilatory activities of Isosorbide mononitrate.]
[A11HA07, inositol, Isosorbide mononitrate may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Isosorbide mononitrate may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Isosorbide mononitrate may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Articaine.]
[A10BH01, sitagliptin, Isosorbide mononitrate may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05CH02, ramelteon, Ramelteon may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C07AA01, alprenolol, Isosorbide mononitrate may increase the hypotensive activities of Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Isosorbide mononitrate may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[G04BE01, alprostadil, Alprostadil may increase the vasodilatory activities of Isosorbide mononitrate.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Imidapril.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Isosorbide mononitrate.]
[J04AC01, isoniazid, Isoniazid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J05AX05, inosine pranobex, Isosorbide mononitrate may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C05AE02, isosorbide dinitrate, Isosorbide dinitrate may increase the vasodilatory activities of Isosorbide mononitrate.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C04AA01, isoxsuprine, Isoxsuprine may increase the vasodilatory activities of Isosorbide mononitrate.]
[S01AA24, kanamycin, Isosorbide mononitrate may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Ketamine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C02KD01, ketanserin, Isosorbide mononitrate may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, Isosorbide mononitrate may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[N05AH03, olanzapine, The risk or severity of adverse effects can be increased when Olanzapine is combined with Isosorbide mononitrate.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N04BC09, rotigotine, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Rotigotine.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may increase the vasodilatory activities of Isosorbide mononitrate.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C02AA05, deserpidine, Isosorbide mononitrate may increase the hypotensive activities of Deserpidine.]
[A06AX03, lubiprostone, Isosorbide mononitrate may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Isosorbide mononitrate is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Isosorbide mononitrate.]
[C08EX01, lidoflazine, Lidoflazine may increase the vasodilatory activities of Isosorbide mononitrate.]
[S01AA21, amikacin, Isosorbide mononitrate may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA03, loperamide, Loperamide may increase the vasodilatory activities of Isosorbide mononitrate.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[B05XA11, magnesium chloride, Isosorbide mononitrate may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Isosorbide mononitrate may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the vasodilatory activities of Isosorbide mononitrate.]
[L01BA05, pralatrexate, Isosorbide mononitrate may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Isosorbide mononitrate.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Isosorbide mononitrate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Isosorbide mononitrate.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Mepivacaine is combined with Isosorbide mononitrate.]
[G04BX16, tiopronin, Isosorbide mononitrate may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Isosorbide mononitrate may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06BA03, methamphetamine, Isosorbide mononitrate may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L01BA04, pemetrexed, Isosorbide mononitrate may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Isosorbide mononitrate.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The risk or severity of adverse effects can be increased when Methyldopa is combined with Isosorbide mononitrate.]
[V04CG05, methylene blue, Methylene blue may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[G03EK01, methyltestosterone, Isosorbide mononitrate may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The risk or severity of adverse effects can be increased when Metoprolol is combined with Isosorbide mononitrate.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of adverse effects can be increased when Valsartan is combined with Isosorbide mononitrate.]
[D11AX01, minoxidil, Minoxidil may increase the vasodilatory activities of Isosorbide mononitrate.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Isosorbide mononitrate.]
[C01DX12, molsidomine, Molsidomine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C01BD01, amiodarone, Amiodarone may increase the vasodilatory activities of Isosorbide mononitrate.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Isosorbide mononitrate.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Isosorbide mononitrate may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Isosorbide mononitrate may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Isosorbide mononitrate may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Isosorbide mononitrate.]
[C07AA12, nadolol, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Nadolol.]
[J01CA04, amoxicillin, Isosorbide mononitrate may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Isosorbide mononitrate.]
[C04AX21, nafronyl, Naftidrofuryl may increase the vasodilatory activities of Isosorbide mononitrate.]
[V03AB15, naloxone, Isosorbide mononitrate may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Isosorbide mononitrate is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Isosorbide mononitrate.]
[S03AA01, neomycin, Isosorbide mononitrate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Remifentanil is combined with Isosorbide mononitrate.]
[C01CX08, levosimendan, Levosimendan may increase the vasodilatory activities of Isosorbide mononitrate.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isosorbide mononitrate.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[L03AX16, plerixafor, Isosorbide mononitrate may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Isosorbide mononitrate may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Isosorbide mononitrate may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, The risk or severity of adverse effects can be increased when Telmisartan is combined with Isosorbide mononitrate.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01CE01, inamrinone, Amrinone may increase the vasodilatory activities of Isosorbide mononitrate.]
[C10AD02, niacin, Niacin may increase the vasodilatory activities of Isosorbide mononitrate.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[C08CA04, nicardipine, Nicardipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C04AE02, nicergoline, Nicergoline may increase the vasodilatory activities of Isosorbide mononitrate.]
[C10AD05, nicotinyl alcohol, Nicotinyl alcohol may increase the vasodilatory activities of Isosorbide mononitrate.]
[C08CA05, nifedipine, Nifedipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[V03AB22, amyl nitrite, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C08CA07, nisoldipine, Nisoldipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C08CA08, nitrendipine, Nitrendipine may increase the vasodilatory activities of Isosorbide mononitrate.]
[R07AX01, nitric oxide, The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Isosorbide mononitrate.]
[J01XE01, nitrofurantoin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Isosorbide mononitrate.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Isosorbide mononitrate.]
[C02DD01, nitroprusside, Nitroprusside may increase the vasodilatory activities of Isosorbide mononitrate.]
[N01AX13, nitrous oxide, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Nitrous oxide.]
[C02KX01, bosentan, Bosentan may increase the vasodilatory activities of Isosorbide mononitrate.]
[G02CA02, nylidrin, Nylidrin may increase the vasodilatory activities of Isosorbide mononitrate.]
[N02AA02, opium, Isosorbide mononitrate may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isosorbide mononitrate.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C07AA02, oxprenolol, Oxprenolol may increase the vasodilatory activities of Isosorbide mononitrate.]
[C01DX03, oxyfedrine, Oxyfedrine may increase the vasodilatory activities of Isosorbide mononitrate.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Isosorbide mononitrate.]
[J04AB30, capreomycin, Isosorbide mononitrate may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, Papaverine may increase the vasodilatory activities of Isosorbide mononitrate.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[G04BD11, fesoterodine, Isosorbide mononitrate may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Penbutolol.]
[N05AG03, penfluridol, Penfluridol may increase the vasodilatory activities of Isosorbide mononitrate.]
[J01CE09, penicillin G procaine, Isosorbide mononitrate may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Isosorbide mononitrate.]
[L01XX08, pentostatin, Isosorbide mononitrate may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the vasodilatory activities of Isosorbide mononitrate.]
[C08EX02, perhexiline, Perhexiline may increase the vasodilatory activities of Isosorbide mononitrate.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Phenazopyridine.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[N03AA02, phenobarbital, Phenobarbital may increase the hypotensive activities of Isosorbide mononitrate.]
[C04AX02, phenoxybenzamine, Phenoxybenzamine may increase the vasodilatory activities of Isosorbide mononitrate.]
[V03AB36, phentolamine, Phentolamine may increase the vasodilatory activities of Isosorbide mononitrate.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N03AB02, phenytoin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Isosorbide mononitrate.]
[S01AE05, levofloxacin, Isosorbide mononitrate may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Isosorbide mononitrate may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C08CX01, mibefradil, Mibefradil may increase the vasodilatory activities of Isosorbide mononitrate.]
[C07AA03, pindolol, Pindolol may increase the vasodilatory activities of Isosorbide mononitrate.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N06BX03, piracetam, Isosorbide mononitrate may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Eprosartan is combined with Isosorbide mononitrate.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C09CA04, irbesartan, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Irbesartan.]
[A10BG02, rosiglitazone, Rosiglitazone may increase the vasodilatory activities of Isosorbide mononitrate.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BH03, saxagliptin, Isosorbide mononitrate may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C07AB01, practolol, Isosorbide mononitrate may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, Prazosin may increase the vasodilatory activities of Isosorbide mononitrate.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01DX02, prenylamine, Prenylamine may increase the vasodilatory activities of Isosorbide mononitrate.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Primaquine.]
[N03AA03, primidone, Primidone may increase the hypotensive activities of Isosorbide mononitrate.]
[M04AB01, probenecid, Isosorbide mononitrate may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, Isosorbide mononitrate may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, Procaine may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[L01XB01, procarbazine, Procarbazine may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[C10AB05, fenofibrate, Isosorbide mononitrate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R06AD02, promethazine, Isosorbide mononitrate may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Propofol is combined with Isosorbide mononitrate.]
[C07AA05, propranolol, Propranolol may increase the vasodilatory activities of Isosorbide mononitrate.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[B01AC09, epoprostenol, Epoprostenol may increase the vasodilatory activities of Isosorbide mononitrate.]
[N05AX12, aripiprazole, Aripiprazole may increase the hypotensive activities of Isosorbide mononitrate.]
[N07XX07, dalfampridine, Isosorbide mononitrate may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Isosorbide mononitrate may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C01BA01, quinidine, Isosorbide mononitrate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The risk or severity of methemoglobinemia can be increased when Quinine is combined with Isosorbide mononitrate.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[C02AA01, rescinnamine, Isosorbide mononitrate may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Isosorbide mononitrate.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[A07EC01, sulfasalazine, The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Isosorbide mononitrate.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Isosorbide mononitrate.]
[N04BD01, selegiline, Selegiline may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Obinutuzumab.]
[J01GB08, sisomicin, Isosorbide mononitrate may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Isosorbide mononitrate may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Isosorbide mononitrate may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Isosorbide mononitrate.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[J01GA01, streptomycin, Isosorbide may increase the excretion rate of Streptomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BX02, sucralfate, Isosorbide may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CG01, sulbactam, Isosorbide may increase the excretion rate of Sulbactam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01EC02, sulfadiazine, Isosorbide may increase the excretion rate of Sulfadiazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01EC01, sulfamethoxazole, Isosorbide may increase the excretion rate of Sulfamethoxazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD07, temazepam, Isosorbide may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC03, terbutaline, Isosorbide may increase the excretion rate of Terbutaline which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AE07, dabigatran etexilate, Isosorbide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.]
[G03BA03, testosterone, Isosorbide may increase the excretion rate of Testosterone which could result in a lower serum level and potentially a reduction in efficacy.]
[S03AA02, tetracycline, Isosorbide may increase the excretion rate of Tetracycline which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Isosorbide may increase the excretion rate of Thiabendazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AD03, thiethylperazine, Isosorbide may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE06, moxisylyte, Isosorbide may increase the excretion rate of Moxisylyte which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AL03, tiapride, Isosorbide may increase the excretion rate of Tiapride which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC05, ticlopidine, Isosorbide may increase the excretion rate of Ticlopidine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX01, tilidine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Tilidine.]
[S01ED01, timolol, Isosorbide may increase the excretion rate of Timolol which could result in a lower serum level and potentially a reduction in efficacy.]
[P01AB02, tinidazole, Isosorbide may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA12, tobramycin, Isosorbide may increase the excretion rate of Tobramycin which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB05, tolazamide, Isosorbide may increase the excretion rate of Tolazamide which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CA01, tolbutamide, Isosorbide may increase the excretion rate of Tolbutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX02, tramadol, Isosorbide may increase the excretion rate of Tramadol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Isosorbide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Isosorbide may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AD02, trifluridine, Isosorbide may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AA05, trimebutine, Trimebutine may increase the vasodilatory activities of Isosorbide.]
[N03AC02, trimethadione, Trimethadione may increase the vasodilatory activities of Isosorbide.]
[J01EA01, trimethoprim, Isosorbide may increase the excretion rate of Trimethoprim which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DX07, roflumilast, Isosorbide may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.]
[L01FX04, ipilimumab, Isosorbide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AA14, oxyquinoline, Isosorbide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA28, vancomycin, Isosorbide may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX21, ezogabine, Isosorbide may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AF01, rivaroxaban, Isosorbide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[C08DA01, verapamil, Verapamil may increase the vasodilatory activities of Isosorbide.]
[N06AX09, viloxazine, Isosorbide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.]
[B03BA01, vitamin B12, Isosorbide may increase the excretion rate of Cyanocobalamin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AA03, warfarin, Isosorbide may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA05, tiludronic acid, Isosorbide may increase the excretion rate of Tiludronic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[B06AC02, icatibant, Isosorbide may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC04, rabeprazole, Isosorbide may increase the excretion rate of Rabeprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Isosorbide may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Isosorbide which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Isosorbide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD07, tolterodine, Isosorbide may increase the excretion rate of Tolterodine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DH04, doripenem, Isosorbide may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.]
[M01CB03, auranofin, Isosorbide may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.]
[B03XA04, peginesatide, Isosorbide may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC07, azacitidine, Isosorbide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX01, azathioprine, Isosorbide may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC05, gemcitabine, Isosorbide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DF01, aztreonam, Isosorbide may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE10, avanafil, Avanafil may increase the hypotensive activities of Isosorbide.]
[M03BX01, baclofen, Isosorbide may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA11, lorcaserin, Isosorbide may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD12, mirabegron, Isosorbide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BB04, enzalutamide, Isosorbide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX04, linaclotide, The risk or severity of adverse effects can be increased when Isosorbide is combined with Linaclotide.]
[D02BA02, octinoxate, Isosorbide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BD02, rasagiline, Isosorbide may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA13, lercanidipine, Lercanidipine may increase the vasodilatory activities of Isosorbide.]
[V09IX04, fluorodeoxyglucose F18, Isosorbide may increase the excretion rate of Fludeoxyglucose (18F) which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE03, sildenafil, The risk or severity of hypotension can be increased when Isosorbide is combined with Sildenafil.]
[V08CA11, gadofosveset, Isosorbide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX08, teduglutide, Isosorbide may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AX11, bencyclane, Bencyclane may increase the vasodilatory activities of Isosorbide.]
[A10BH04, alogliptin, Isosorbide may increase the excretion rate of Alogliptin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX09, glycerol phenylbutyrate, Isosorbide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Isosorbide may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BK02, canagliflozin, Isosorbide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX06, tegaserod, The risk or severity of adverse effects can be increased when Isosorbide is combined with Tegaserod.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Isosorbide.]
[L03AA12, ancestim, Isosorbide may increase the excretion rate of Ancestim which could result in a lower serum level and potentially a reduction in efficacy.]
[N04AC01, benztropine, Isosorbide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AX03, benzydamine, Isosorbide may increase the excretion rate of Benzydamine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EE01, trametinib, Isosorbide may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AX05, florbetapir F-18, Isosorbide may increase the excretion rate of Florbetapir (18F) which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX28, levomilnacipran, Isosorbide may increase the excretion rate of Levomilnacipran which could result in a lower serum level and potentially a reduction in efficacy.]
[C08EA02, bepridil, Bepridil may increase the vasodilatory activities of Isosorbide.]
[C02KX05, riociguat, Isosorbide may increase the hypotensive activities of Riociguat.]
[A10BJ03, lixisenatide, Isosorbide may increase the excretion rate of Lixisenatide which could result in a lower serum level and potentially a reduction in efficacy.]
[C02KX04, macitentan, Isosorbide may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX26, vortioxetine, Isosorbide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.]
[G03AC08, etonogestrel, Isosorbide may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AP08, sofosbuvir, Isosorbide may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Isosorbide may increase the excretion rate of Droxidopa which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH03, tasimelteon, Isosorbide may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA32, apremilast, Isosorbide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BG02, formestane, Isosorbide may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB34, fomepizole, Isosorbide may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BK03, empagliflozin, Empagliflozin may increase the diuretic activities of Isosorbide.]
[V08AA01, diatrizoic acid, Isosorbide may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AA04, iothalamic acid, Isosorbide may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB04, phenolphthalein, The risk or severity of adverse effects can be increased when Isosorbide is combined with Phenolphthalein.]
[A06AH03, naloxegol, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Naloxegol.]
[A06AG02, bisacodyl, The risk or severity of adverse effects can be increased when Isosorbide is combined with Bisacodyl.]
[B01AF03, edoxaban, Isosorbide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BE01, acetaminophen, Isosorbide may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy.]
[L01DC01, bleomycin, Isosorbide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA06, eluxadoline, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Eluxadoline.]
[A06AD03, magnesium peroxide, The risk or severity of adverse effects can be increased when Isosorbide is combined with Magnesium peroxide.]
[M02AA25, aceclofenac, Isosorbide may increase the excretion rate of Aceclofenac which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AB11, acemetacin, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Acemetacin.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Isosorbide.]
[V03AB37, idarucizumab, Isosorbide may increase the excretion rate of Idarucizumab which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG03, ixazomib, Isosorbide may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy.]
[M04AB05, lesinurad, Isosorbide may increase the excretion rate of Lesinurad which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX23, brivaracetam, Isosorbide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA08, bromazepam, Isosorbide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[A02AD05, aluminum magnesium silicate, Isosorbide may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA01, amlodipine, Amlodipine may increase the vasodilatory activities of Isosorbide.]
[C03CA02, bumetanide, Isosorbide may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, Isosorbide may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BC01, buprenorphine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Buprenorphine.]
[N05BE01, buspirone, Isosorbide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XX27, arsenic trioxide, Isosorbide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA03, clofezone, Isosorbide may increase the excretion rate of Rabeprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AF01, butorphanol, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Butorphanol.]
[A06AX07, plecanatide, The risk or severity of adverse effects can be increased when Isosorbide is combined with Plecanatide.]
[A06AH05, naldemedine, Isosorbide may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX16, deutetrabenazine, Isosorbide may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BF02, pregabalin, Isosorbide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA02, benznidazole, Isosorbide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF06, abacavir, Isosorbide may increase the excretion rate of Abacavir which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX13, valbenazine, Isosorbide may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA23, delafloxacin, Isosorbide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC06, capecitabine, Isosorbide may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB07, bisoprolol, Isosorbide may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Isosorbide may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Isosorbide may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BB05, apalutamide, Isosorbide may increase the excretion rate of Apalutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AF01, carbamazepine, Isosorbide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC08, calcium polycarbophil, The risk or severity of adverse effects can be increased when Isosorbide is combined with Calcium polycarbophil.]
[C07AG02, carvedilol, Carvedilol may increase the vasodilatory activities of Isosorbide.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Isosorbide.]
[L04AA37, baricitinib, Isosorbide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD14, ceftibuten, Isosorbide may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.]
[J01GB14, plazomicin, Isosorbide may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX14, migalastat, Isosorbide may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX17, stiripentol, Isosorbide may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy.]
[S01GX12, cetirizine, Isosorbide may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy.]
[D08AE05, chloroxylenol, Isosorbide may increase the excretion rate of Chloroxylenol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01AD01, carmustine, Isosorbide may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX05, prucalopride, The risk or severity of adverse effects can be increased when Isosorbide is combined with Prucalopride.]
[B01AC23, cilostazol, Isosorbide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA14, solriamfetol, Isosorbide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA09, clobazam, Isosorbide may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB05, castor oil, The risk or severity of adverse effects can be increased when Isosorbide is combined with Castor oil.]
[J01DC04, cefaclor, Isosorbide may increase the excretion rate of Cefaclor which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DB05, cefadroxil, Isosorbide may increase the excretion rate of Cefadroxil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DC05, cefotetan, Isosorbide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD02, ceftazidime, Isosorbide may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD04, ceftriaxone, Isosorbide may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX11, pitolisant, Isosorbide may increase the excretion rate of Pitolisant which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Isosorbide.]
[A06AB03, danthron, The risk or severity of adverse effects can be increased when Isosorbide is combined with Dantron.]
[J01XX09, daptomycin, Isosorbide may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DB01, cephalexin, Isosorbide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DB09, cephradine, Isosorbide may increase the excretion rate of Cefradine which could result in a lower serum level and potentially a reduction in efficacy.]
[M09AX08, golodirsen, Isosorbide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA12, dexpanthenol, Isosorbide may increase the excretion rate of Dexpanthenol which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX03, dezocine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Dezocine.]
[R02AA03, dichlorobenzyl alcohol, Isosorbide may increase the excretion rate of Dichlorobenzyl alcohol which could result in a lower serum level and potentially a reduction in efficacy.]
[G03DB08, dienogest, Isosorbide may increase the excretion rate of Dienogest which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA08, dihydrocodeine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Dihydrocodeine.]
[C08CA16, clevidipine, Clevidipine may increase the vasodilatory activities of Isosorbide.]
[V08CA05, mangafodipir, Isosorbide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA27, dexketoprofen, Isosorbide may increase the excretion rate of Dexketoprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA17, levamlodipine, Levamlodipine may increase the vasodilatory activities of Isosorbide.]
[N02AX07, oliceridine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Oliceridine.]
[P01BA01, chloroquine, Isosorbide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Isosorbide may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB02, chlorpropamide, Isosorbide may increase the excretion rate of Chlorpropamide which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Isosorbide may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA03, choline salicylate, Isosorbide may increase the excretion rate of Choline salicylate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX18, vinpocetine, Vinpocetine may increase the vasodilatory activities of Isosorbide.]
[M01AB08, etodolac, Isosorbide may increase the excretion rate of Etodolac which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AX25, chondroitin sulfates, Isosorbide may increase the excretion rate of Chondroitin sulfate which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA19, fenoldopam, Isosorbide may increase the excretion rate of Fenoldopam which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD15, cefdinir, Isosorbide may increase the excretion rate of Cefdinir which could result in a lower serum level and potentially a reduction in efficacy.]
[S02BA08, fluocinolone acetonide, Isosorbide may increase the excretion rate of Fluocinolone acetonide which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BG07, flupirtine, Isosorbide may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Isosorbide.]
[A02BA01, cimetidine, Isosorbide may increase the excretion rate of Cimetidine which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA04, gadoteridol, Isosorbide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.]
[N07CA02, cinnarizine, Cinnarizine may increase the vasodilatory activities of Isosorbide.]
[S03AA07, ciprofloxacin, Isosorbide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA01, cisplatin, Isosorbide may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AB03, ioflupane I-123, Isosorbide may increase the excretion rate of Ioflupane I-123 which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AA01, technetium Tc 99m exametazime, Isosorbide may increase the excretion rate of Technetium Tc-99m exametazime which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AX06, florbetaben f-18, Isosorbide may increase the excretion rate of Florbetaben (18F) which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB10, levobupivacaine, Isosorbide may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA04, clomipramine, Isosorbide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AE01, clonazepam, Isosorbide may increase the excretion rate of Clonazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AH02, oseltamivir, Isosorbide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Isosorbide may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA04, codeine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Codeine.]
[M04AC01, colchicine, Isosorbide may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy.]
[A04AA03, tropisetron, Isosorbide may increase the excretion rate of Tropisetron which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BX03, nateglinide, Isosorbide may increase the excretion rate of Nateglinide which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Isosorbide.]
[J05AB14, valganciclovir, Isosorbide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C05BB03, invert sugar, Isosorbide may increase the excretion rate of Invert sugar which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB09, iodixanol, Isosorbide may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB05, iopromide, Isosorbide may increase the excretion rate of Iopromide which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB07, ioversol, Isosorbide may increase the excretion rate of Ioversol which could result in a lower serum level and potentially a reduction in efficacy.]
[V08AB12, ioxilan, Isosorbide may increase the excretion rate of Ioxilan which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CC05, almotriptan, Isosorbide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AD03, acyclovir, Isosorbide may increase the excretion rate of Acyclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA10, ketazolam, Isosorbide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA09, lacidipine, Lacidipine may increase the vasodilatory activities of Isosorbide.]
[A06AD12, lactitol, The risk or severity of adverse effects can be increased when Isosorbide is combined with Lactitol.]
[N03AX09, lamotrigine, Isosorbide may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BC04, lofexidine, Isosorbide may increase the excretion rate of Lofexidine which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA03, lisinopril, Isosorbide may increase the excretion rate of Lisinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AD01, magnesium carbonate, The risk or severity of adverse effects can be increased when Isosorbide is combined with Magnesium carbonate.]
[C08CA11, manidipine, Manidipine may increase the vasodilatory activities of Isosorbide.]
[J01DH02, meropenem, Isosorbide may increase the excretion rate of Meropenem which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AX01, cyclandelate, Cyclandelate may increase the vasodilatory activities of Isosorbide.]
[N05AD03, metylperon, Isosorbide may increase the excretion rate of Melperone which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Isosorbide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE09, vardenafil, The risk or severity of hypotension can be increased when Vardenafil is combined with Isosorbide.]
[L01AX04, dacarbazine, Isosorbide may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BB05, nalmefene, Isosorbide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA15, potassium lactate, The risk or severity of adverse effects can be increased when Isosorbide is combined with Potassium lactate.]
[S01GX04, nedocromil, Isosorbide may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX06, nefazodone, Isosorbide may increase the excretion rate of Nefazodone which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DX16, nicorandil, Isosorbide may increase the excretion rate of Nicorandil which could result in a lower serum level and potentially a reduction in efficacy.]
[L02BB02, nilutamide, Isosorbide may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA23, theodrenaline, The risk or severity of Cardiac Arrhythmia can be increased when Theodrenaline is combined with Isosorbide.]
[R05DA06, normethadone, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Normethadone.]
[B01AX05, fondaparinux, Isosorbide may increase the excretion rate of Fondaparinux which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA01, desipramine, Isosorbide may increase the excretion rate of Desipramine which could result in a lower serum level and potentially a reduction in efficacy.]
[H01BA02, desmopressin, Isosorbide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CH02, indigo carmine, Isosorbide may increase the excretion rate of Indigotindisulfonic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DH03, ertapenem, Isosorbide may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AE12, oxaprozin, Isosorbide may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA02, dextroamphetamine, Isosorbide may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AC01, dextromoramide, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Dextromoramide.]
[N07BC06, heroin, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Diamorphine.]
[P03AC04, permethrin, Isosorbide may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA01, diazepam, Isosorbide may increase the excretion rate of Diazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA08, pholcodine, Isosorbide may increase the excretion rate of Pholcodine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AA07, dicyclomine, Isosorbide may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF02, didanosine, Isosorbide may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AX04, pinaverium, Pinaverium may increase the vasodilatory activities of Isosorbide.]
[C08CA03, isradipine, Isradipine may increase the vasodilatory activities of Isosorbide.]
[D07XC04, diflucortolone, Isosorbide may increase the excretion rate of Difluocortolone which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA11, diflunisal, Isosorbide may increase the excretion rate of Diflunisal which could result in a lower serum level and potentially a reduction in efficacy.]
[C01AA05, digoxin, Isosorbide may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA03, hydromorphone, Isosorbide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX04, lenalidomide, Isosorbide may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BC01, potassium perchlorate, Isosorbide may increase the excretion rate of Potassium perchlorate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB04, pralidoxime, Isosorbide may increase the excretion rate of Pralidoxime which could result in a lower serum level and potentially a reduction in efficacy.]
[C08DB01, diltiazem, Diltiazem may increase the vasodilatory activities of Isosorbide.]
[V03AB09, dimercaprol, Isosorbide may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AX03, dimethyl sulfoxide, Isosorbide may increase the excretion rate of Dimethyl sulfoxide which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA01, diphenoxylate, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Diphenoxylate.]
[B01AC07, dipyridamole, The risk or severity of hypotension can be increased when Dipyridamole is combined with Isosorbide.]
[S01AX06, resorcinol, Isosorbide may increase the excretion rate of Resorcinol which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BA03, disopyramide, Isosorbide may increase the excretion rate of Disopyramide which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AE09, levocetirizine, Isosorbide may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB09, ropivacaine, Isosorbide may increase the excretion rate of Ropivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, The risk or severity of hypotension can be increased when Tadalafil is combined with Isosorbide.]
[C01EB18, ranolazine, Isosorbide may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy.]
[H05BA01, salmon calcitonin, Isosorbide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA07, dobutamine, Isosorbide may increase the excretion rate of Dobutamine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA04, dopamine, Isosorbide may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA12, doxepin, Isosorbide may increase the excretion rate of Doxepin which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB06, sennosides, USP, The risk or severity of adverse effects can be increased when Isosorbide is combined with Sennosides.]
[J01AA02, doxycycline, Isosorbide may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA10, sibutramine, Isosorbide may increase the excretion rate of Sibutramine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AG05, sodium phosphate, Isosorbide may increase the nephrotoxic activities of Sodium phosphate, monobasic.]
[A12CA02, sodium sulfate, The risk or severity of adverse effects can be increased when Isosorbide is combined with Sodium sulfate.]
[R03DA01, dyphylline, Isosorbide may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CC01, sumatriptan, Isosorbide may increase the excretion rate of Sumatriptan which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CX07, edrophonium, Isosorbide may increase the excretion rate of Edrophonium which could result in a lower serum level and potentially a reduction in efficacy.]
[L01AX03, temozolomide, Isosorbide may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD05, terodiline, Terodiline may increase the vasodilatory activities of Isosorbide.]
[N06AG03, toloxatone, Isosorbide may increase the excretion rate of Toloxatone which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA09, atomoxetine, Isosorbide may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX11, topiramate, Isosorbide may increase the excretion rate of Topiramate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Isosorbide may increase the excretion rate of Chloral hydrate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01FB02, ephedrine, The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Isosorbide.]
[N06AX16, venlafaxine, Isosorbide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, Barnidipine may increase the vasodilatory activities of Isosorbide.]
[S01EA01, epinephrine, The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Isosorbide.]
[N03AX15, zonisamide, Zonisamide may increase the vasodilatory activities of Isosorbide.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Isosorbide.]
[L01XA02, carboplatin, Isosorbide may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC02, guanfacine, Isosorbide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AX05, pidotimod, Isosorbide may increase the excretion rate of Pidotimod which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD04, estazolam, Isosorbide may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC02, pantoprazole, Isosorbide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA03, estradiol, Isosorbide may increase the excretion rate of Estradiol which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Isosorbide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[J04AK02, ethambutol, Isosorbide may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy.]
[V08CA03, gadodiamide, Isosorbide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BD05, ibutilide, Isosorbide may increase the excretion rate of Ibutilide which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AD01, ethosuximide, Ethosuximide may increase the vasodilatory activities of Isosorbide.]
[M01AC06, meloxicam, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Meloxicam.]
[S01XA06, ethylmorphine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Ethylmorphine.]
[N01AX07, etomidate, Isosorbide may increase the excretion rate of Etomidate which could result in a lower serum level and potentially a reduction in efficacy.]
[P01AX07, trimetrexate, Isosorbide may increase the excretion rate of Trimetrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX12, bupropion, Isosorbide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AB08, fluvoxamine, Isosorbide may increase the excretion rate of Fluvoxamine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AE02, leuprolide, Isosorbide may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy.]
[M01CB01, gold sodium thiomalate, Isosorbide may increase the excretion rate of Sodium aurothiomalate which could result in a lower serum level and potentially a reduction in efficacy.]
[B05AA05, dextran, Isosorbide may increase the excretion rate of Dextran which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AF02, dexrazoxane, Isosorbide may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AA01, levocarnitine, Isosorbide may increase the excretion rate of Levocarnitine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA02, felodipine, Felodipine may increase the vasodilatory activities of Isosorbide.]
[C08EA01, fendiline, Fendiline may increase the vasodilatory activities of Isosorbide.]
[N02AB03, fentanyl, Isosorbide may increase the excretion rate of Fentanyl which could result in a lower serum level and potentially a reduction in efficacy.]
[R03CC02, albuterol, Isosorbide may increase the excretion rate of Salbutamol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BB06, clofarabine, Isosorbide may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07AX03, cevimeline, Isosorbide may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD02, flavoxate, Isosorbide may increase the excretion rate of Flavoxate which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AC01, fluconazole, Isosorbide may increase the excretion rate of Fluconazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AX01, flucytosine, Isosorbide may increase the excretion rate of Flucytosine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB25, flumazenil, Isosorbide may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy.]
[N07CA03, flunarizine, Flunarizine may increase the vasodilatory activities of Isosorbide.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive and vasodilatory activities of Isosorbide.]
[L01BC09, floxuridine, Isosorbide may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD01, flurazepam, Isosorbide may increase the excretion rate of Flurazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC04, flurbiprofen, Isosorbide may increase the excretion rate of Flurbiprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AG01, fluspirilene, Fluspirilene may increase the vasodilatory activities of Isosorbide.]
[L02BB01, flutamide, Isosorbide may increase the excretion rate of Flutamide which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CX02, folic acid, Isosorbide may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[S02AA17, fosfomycin, Isosorbide may increase the excretion rate of Fosfomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC03, tegafur, Isosorbide may increase the excretion rate of Tegafur which could result in a lower serum level and potentially a reduction in efficacy.]
[C03CA01, furosemide, Isosorbide may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Isosorbide may increase the excretion rate of Eszopiclone which could result in a lower serum level and potentially a reduction in efficacy.]
[C08DA02, gallopamil, Gallopamil may increase the vasodilatory activities of Isosorbide.]
[S01AD09, ganciclovir, Isosorbide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AB04, gemfibrozil, Isosorbide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XA03, telavancin, Isosorbide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AD03, methsuximide, Methsuximide may increase the vasodilatory activities of Isosorbide.]
[N01AH02, alfentanil, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Alfentanil.]
[A10BB07, glipizide, Isosorbide may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CM18, dexmedetomidine, Isosorbide may increase the excretion rate of Dexmedetomidine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AX01, glycerin, The risk or severity of adverse effects can be increased when Isosorbide is combined with Glycerin.]
[L01EX02, sorafenib, Isosorbide may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.]
[M01CB04, aurothioglucose, Isosorbide may increase the excretion rate of Aurothioglucose which could result in a lower serum level and potentially a reduction in efficacy.]
[S01LA03, pegaptanib, Isosorbide may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA09, fosinopril, Isosorbide may increase the excretion rate of Fosinopril which could result in a lower serum level and potentially a reduction in efficacy.]
[S01EX01, guanethidine, Isosorbide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AE03, goserelin, Isosorbide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD01, haloperidol, Isosorbide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH04, quetiapine, Isosorbide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX13, idebenone, Isosorbide may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Isosorbide.]
[M04AA01, allopurinol, Isosorbide may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.]
[B05CB03, magnesium citrate, The risk or severity of adverse effects can be increased when Isosorbide is combined with Magnesium citrate.]
[G03DC01, allylestrenol, Isosorbide may increase the excretion rate of Allylestrenol which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CE02, milrinone, Isosorbide may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy.]
[A12CD02, sodium monofluorophosphate, The risk or severity of adverse effects can be increased when Isosorbide is combined with Sodium fluorophosphate.]
[C08CA10, nilvadipine, Nilvadipine may increase the vasodilatory activities of Isosorbide.]
[M02AA26, nimesulide, Nimesulide may increase the vasodilatory activities of Isosorbide.]
[C09AA04, perindopril, Isosorbide may increase the excretion rate of Perindopril which could result in a lower serum level and potentially a reduction in efficacy.]
[C02DB02, hydralazine, Isosorbide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Hydrocodone.]
[B05XA17, potassium acetate, Isosorbide may increase the excretion rate of Potassium acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Isosorbide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD06, propiverine, Isosorbide may increase the excretion rate of Propiverine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05AA07, hetastarch, Isosorbide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AX02, ibuprofen, Isosorbide may increase the excretion rate of Ibuprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA08, sodium acetate, Isosorbide may increase the excretion rate of Sodium acetate which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AD21, sodium tartrate, The risk or severity of adverse effects can be increased when Isosorbide is combined with Sodium tartrate.]
[L01AA06, ifosfamide, Isosorbide may increase the excretion rate of Ifosfamide which could result in a lower serum level and potentially a reduction in efficacy.]
[N01AH03, sufentanil, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Sufentanil.]
[N06AA02, imipramine, Isosorbide may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AD07, tixocortol, Isosorbide may increase the excretion rate of Tixocortol which could result in a lower serum level and potentially a reduction in efficacy.]
[L01CE01, topotecan, Isosorbide may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA11, indapamide, Isosorbide may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.]
[A11HA07, inositol, Isosorbide may increase the excretion rate of Inositol which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX17, milnacipran, Isosorbide may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA28, varenicline, Isosorbide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BH01, sitagliptin, Isosorbide may increase the excretion rate of Sitagliptin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA12, alprazolam, Isosorbide may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH02, ramelteon, Isosorbide may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Isosorbide may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy.]
[J04AC01, isoniazid, Isosorbide may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AX05, inosine pranobex, Isosorbide may increase the excretion rate of Inosine pranobex which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DA05, pentaerythritol tetranitrate, Isosorbide may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.]
[D10BA01, isotretinoin, Isosorbide may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N01AX03, ketamine, Isosorbide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC22, prasugrel, Isosorbide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA10, ketoprofen, Isosorbide may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AG01, labetalol, Isosorbide may increase the excretion rate of Labetalol which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BB01, amantadine, Isosorbide may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AD11, lactulose, The risk or severity of adverse effects can be increased when Isosorbide is combined with Lactulose.]
[A06AX03, lubiprostone, The risk or severity of adverse effects can be increased when Isosorbide is combined with Lubiprostone.]
[C08EX01, lidoflazine, Lidoflazine may increase the vasodilatory activities of Isosorbide.]
[A07DA03, loperamide, Loperamide may increase the vasodilatory activities of Isosorbide.]
[N05BA06, lorazepam, Isosorbide may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA11, magnesium chloride, Isosorbide may increase the excretion rate of Magnesium chloride which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BX01, magnesium hydroxide, The risk or severity of adverse effects can be increased when Isosorbide is combined with Magnesium hydroxide.]
[A12CC10, magnesium oxide, The risk or severity of adverse effects can be increased when Isosorbide is combined with Magnesium oxide.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the vasodilatory activities of Isosorbide.]
[L01BA05, pralatrexate, Isosorbide may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Isosorbide is combined with Mannitol.]
[N06AA21, maprotiline, Isosorbide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy.]
[C02BB01, mecamylamine, Isosorbide may increase the excretion rate of Mecamylamine which could result in a lower serum level and potentially a reduction in efficacy.]
[M02AA18, meclofenamic acid, Isosorbide may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB07, cascara sagrada, The risk or severity of adverse effects can be increased when Isosorbide is combined with Frangula purshiana bark.]
[N06DX01, memantine, Isosorbide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AB02, meperidine, Isosorbide may increase the excretion rate of Meperidine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB03, mepivacaine, Isosorbide may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AX05, meptazinol, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Meptazinol.]
[G04BX16, tiopronin, Isosorbide may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BC01, mersalyl, Isosorbide may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Isosorbide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BA02, metformin, Isosorbide may increase the excretion rate of Metformin which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BC02, methadone, Isosorbide may increase the excretion rate of Methadone which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA03, methamphetamine, Isosorbide may increase the excretion rate of Metamfetamine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF05, lamivudine, Isosorbide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Isosorbide may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BA04, pemetrexed, Isosorbide may increase the excretion rate of Pemetrexed which could result in a lower serum level and potentially a reduction in efficacy.]
[A11HA02, pyridoxine, Isosorbide may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Isosorbide is combined with Ziconotide.]
[L04AX03, methotrexate, Isosorbide may increase the excretion rate of Methotrexate which could result in a lower serum level and potentially a reduction in efficacy.]
[D05BA02, methoxsalen, Isosorbide may increase the excretion rate of Methoxsalen which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC06, methylcellulose, The risk or severity of adverse effects can be increased when Isosorbide is combined with Methylcellulose.]
[C02AB01, methyldopa, Isosorbide may increase the excretion rate of Methyldopa which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CG05, methylene blue, Isosorbide may increase the excretion rate of Methylene blue which could result in a lower serum level and potentially a reduction in efficacy.]
[G03EK01, methyltestosterone, Isosorbide may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.]
[A03FA01, metoclopramide, Isosorbide may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA08, metolazone, Isosorbide may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Isosorbide may increase the excretion rate of Metoprolol which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CD01, metyrapone, Isosorbide may increase the excretion rate of Metyrapone which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD08, midazolam, Isosorbide may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AA01, mineral oil, The risk or severity of adverse effects can be increased when Isosorbide is combined with Mineral oil.]
[J05AH01, zanamivir, Isosorbide may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AC01, aldesleukin, Isosorbide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Isosorbide.]
[C01BD01, amiodarone, Amiodarone may increase the vasodilatory activities of Isosorbide.]
[N06AA09, amitriptyline, Isosorbide may increase the excretion rate of Amitriptyline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA01, morphine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Morphine.]
[A04AA05, palonosetron, Isosorbide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AB05, certolizumab pegol, Isosorbide may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BA01, ammonium chloride, Isosorbide may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA06, mycophenolic acid, Isosorbide may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA12, nadolol, Isosorbide may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CA04, amoxicillin, Isosorbide may increase the excretion rate of Amoxicillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AF02, nalbuphine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Nalbuphine.]
[V03AB15, naloxone, Isosorbide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BB04, naltrexone, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Naltrexone.]
[N06BA01, amphetamine, Isosorbide may increase the excretion rate of Amphetamine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX21, duloxetine, Isosorbide may increase the excretion rate of Duloxetine which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BX01, tolcapone, Isosorbide may increase the excretion rate of Tolcapone which could result in a lower serum level and potentially a reduction in efficacy.]
[N01AH06, remifentanil, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Remifentanil.]
[B01AC17, tirofiban, Isosorbide may increase the excretion rate of Tirofiban which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA19, ampicillin, Isosorbide may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AX16, plerixafor, Isosorbide may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX23, desvenlafaxine, Isosorbide may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AB11, valacyclovir, Isosorbide may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CE01, inamrinone, Isosorbide may increase the excretion rate of Amrinone which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA04, nicardipine, Nicardipine may increase the vasodilatory activities of Isosorbide.]
[C08CA05, nifedipine, Nifedipine may increase the vasodilatory activities of Isosorbide.]
[C08CA06, nimodipine, Nimodipine may increase the vasodilatory activities of Isosorbide.]
[C08CA07, nisoldipine, Nisoldipine may increase the vasodilatory activities of Isosorbide.]
[C08CA08, nitrendipine, Nitrendipine may increase the vasodilatory activities of Isosorbide.]
[R07AX01, nitric oxide, Isosorbide may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XE01, nitrofurantoin, Isosorbide may increase the excretion rate of Nitrofurantoin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF03, zaleplon, Isosorbide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BC05, pramipexole, Isosorbide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[C02DD01, nitroprusside, Isosorbide may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA03, norepinephrine, The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Isosorbide.]
[G02CA02, nylidrin, Nylidrin may increase the vasodilatory activities of Isosorbide.]
[N02AA02, opium, Isosorbide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.]
[G04CA02, tamsulosin, Isosorbide may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CF04, oxacillin, Isosorbide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA04, oxazepam, Isosorbide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AA05, oxycodone, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Oxycodone.]
[N02AA11, oxymorphone, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Oxymorphone.]
[N02AX06, tapentadol, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Tapentadol.]
[J04AB30, capreomycin, Isosorbide may increase the excretion rate of Capreomycin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BD11, fesoterodine, Isosorbide may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AA23, penbutolol, Isosorbide may increase the excretion rate of Penbutolol which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AG03, penfluridol, Penfluridol may increase the vasodilatory activities of Isosorbide.]
[J01CE09, penicillin G procaine, Isosorbide may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AD01, pentazocine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Pentazocine.]
[N05CA01, pentobarbital, Isosorbide may increase the excretion rate of Pentobarbital which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XX08, pentostatin, Isosorbide may increase the excretion rate of Pentostatin which could result in a lower serum level and potentially a reduction in efficacy.]
[C04AD03, pentoxifylline, Isosorbide may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[C08EX02, perhexiline, Perhexiline may increase the vasodilatory activities of Isosorbide.]
[N02AD02, phenazocine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Phenazocine.]
[G04BX06, phenazopyridine, Isosorbide may increase the excretion rate of Phenazopyridine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AF03, phenelzine, Isosorbide may increase the excretion rate of Phenelzine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AB01, oxyphenisatin, The risk or severity of adverse effects can be increased when Isosorbide is combined with Oxyphenisatin.]
[N01AH04, phenoperidine, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Phenoperidine.]
[V03AB36, phentolamine, Isosorbide may increase the excretion rate of Phentolamine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AE05, levofloxacin, Isosorbide may increase the excretion rate of Levofloxacin which could result in a lower serum level and potentially a reduction in efficacy.]
[B02BA01, vitamin K1, Isosorbide may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AB12, cidofovir, Isosorbide may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CX01, mibefradil, Mibefradil may increase the vasodilatory activities of Isosorbide.]
[C07AA03, pindolol, Isosorbide may increase the excretion rate of Pindolol which could result in a lower serum level and potentially a reduction in efficacy.]
[J01CA12, piperacillin, Isosorbide may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BX03, piracetam, Isosorbide may increase the excretion rate of Piracetam which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AC03, pirinitramide, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Piritramide.]
[S01BC06, piroxicam, Isosorbide may increase the excretion rate of Piroxicam which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BG02, rosiglitazone, The risk or severity of adverse effects can be increased when Isosorbide is combined with Rosiglitazone.]
[A06AD15, polyethylene glycols, The risk or severity of adverse effects can be increased when Isosorbide is combined with Polyethylene glycol.]
[A10BH03, saxagliptin, Isosorbide may increase the excretion rate of Saxagliptin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA01, potassium chloride, Isosorbide may increase the excretion rate of Potassium chloride which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Isosorbide.]
[H02AB07, prednisone, Isosorbide may increase the excretion rate of Prednisone which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DX02, prenylamine, Prenylamine may increase the vasodilatory activities of Isosorbide.]
[M04AB01, probenecid, Isosorbide may increase the excretion rate of Probenecid which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BA02, procainamide, Isosorbide may increase the excretion rate of Procainamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AB05, fenofibrate, Isosorbide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AD02, promethazine, Isosorbide may increase the excretion rate of Promethazine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AB05, propantheline, Isosorbide may increase the excretion rate of Propantheline which could result in a lower serum level and potentially a reduction in efficacy.]
[N02AC04, propoxyphene, The therapeutic efficacy of Isosorbide can be decreased when used in combination with Dextropropoxyphene.]
[C07AA05, propranolol, Isosorbide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CC04, rizatriptan, Isosorbide may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AC09, epoprostenol, Isosorbide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX07, dalfampridine, Isosorbide may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CC01, pyrantel, Isosorbide may increase the excretion rate of Pyrantel which could result in a lower serum level and potentially a reduction in efficacy.]
[J04AK01, pyrazinamide, Isosorbide may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy.]
[C01BA01, quinidine, Isosorbide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BA02, ranitidine, Isosorbide may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AA02, reserpine, Isosorbide may increase the excretion rate of Reserpine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AP01, ribavirin, Isosorbide may increase the excretion rate of Ribavirin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CA06, secobarbital, Isosorbide may increase the excretion rate of Secobarbital which could result in a lower serum level and potentially a reduction in efficacy.]
[A12CD01, sodium fluoride, Isosorbide may increase the excretion rate of Sodium fluoride which could result in a lower serum level and potentially a reduction in efficacy.]
[V04CC01, sorbitol, The risk or severity of adverse effects can be increased when Isosorbide is combined with Sorbitol.]
[D10AX03, azelaic acid, Isosorbide may increase the excretion rate of Azelaic acid which could result in a lower serum level and potentially a reduction in efficacy.]
